Recent Articles from Investor Brand Network

Albuquerque, New Mexico, has launched a new basic income initiative aimed at helping families in areas with high needs. Starting this month, selected households will receive monthly payments with no strings attached. This effort is being partially funded by tax revenue generated from recreational marijuana sales.

Tesla (NASDAQ: TSLA) is set to launch its robotaxi service in Austin, Texas, in June 2025, starting with a limited fleet of approximately 10 vehicles and aiming to scale up to 1,000 within a few months. The rollout will be invite-only and will utilize teleoperators to assist when the autonomous system encounters difficulties. CEO Elon Musk emphasized that the robotaxis will be geofenced to operate only in selected safe areas and will avoid complex intersections unless the system is highly confident in their safety. This cautious approach follows a Business Insider report detailing a test where Tesla’s Full Self-Driving (FSD) Supervised software ran a red light in San Francisco. Musk criticized the comparison, arguing that the test did not accurately reflect the performance of the autonomous software intended for robotaxis, which will be FSD Unsupervised.

Traders Fair Philippines, the region’s premier financial event, returns to Manila on May 24, 2025, at Edsa Shangri-La for a full-day of education, networking, and market insights. Organized by iEvents, the fair will bring together traders, investors, brokers, and financial service providers for a dynamic showcase of industry trends across forex, cryptocurrency, stocks, futures, and options. The event will feature more than 20 esteemed speakers, including leaders from Forex Trading Philippines, PAFTI, and Wise Investors Ph, and offer engaging presentations and workshops. Traders Fair Philippines is part of a global series renowned for fostering professional development and market connectivity across Asia, Africa, LATAM, and other key regions.

Trump Media & Technology Group (NASDAQ: DJT) is under scrutiny following revelations that U.S. Attorney General Pam Bondi sold between $1 million and $5 million worth of the company’s shares on April 2, 2025—the same day President Donald Trump announced significant new tariffs that led to a market downturn. Bondi’s financial disclosure forms indicate the transactions occurred on that date, though it’s unclear whether they were made before or after the market closed. The timing has raised questions about potential conflicts of interest, especially given Bondi’s prior consultancy role with Digital World Acquisition Corp., the special purpose acquisition company that merged with Trump Media to take it public. While Bondi was obligated to divest her holdings within 90 days of her confirmation as attorney general, the specific timing of the sale has prompted calls for further investigation.

Gold ticked upwards on Monday following the weakening of the U.S. dollar after Moody’s downgraded the government of America’s credit rating . This boosted the safe haven appeal of gold and helped the precious metal to register some gains on the day .

Marketing is undergoing a once-in-a-generation transformation, powered by artificial intelligence, real-time data, and next-generation automation. Today’s marketing systems aren’t static; they’re dynamic, adaptive, and personalized in real time. For growth-stage and middle-market businesses, this shift presents both a challenge and an opportunity. Navigating this landscape requires tools that are flexible, insights that are deep, and strategies grounded in data. That’s precisely where ONAR Holding Corp. (OTCQB: ONAR) is establishing itself as a market leader.

SKYX Platforms (NASDAQ: SKYX) announced a major collaboration with SG Holdings for a $3 billion smart city development in Miami’s Little River District. The company will deploy over 500,000 units of its patented plug-and-play smart home technologies across 5,700 planned residences, including affordable housing. SKYX’s platform will power safety and smart features such as voice and app controls, 911 emergency calling, smoke and CO detectors, and more. The project, backed by U.S. and global manufacturers, marks the first development of its kind in Florida and establishes recurring revenue opportunities through subscriptions, monitoring services, and future integrations.

Lelantos Holdings (OTC PINK: LNTO) announced a comprehensive 2025 strategy through its subsidiary, Lelantos Energy, aimed at expanding renewable energy access, advancing credit monetization, and serving underserved communities. Key initiatives include a partnership with NeRD Power for turnkey commercial solar projects, the launch of Free Solar 4 Veterans with The Warrior Up Foundation, and a Sustainable Community Network to bring no-cost solar to over 550 low-income homes in Washington D.C. Through a new joint venture and exclusive sales rights with Coulomb Capital, the company is scaling its efforts in tax credit monetization and entering the federal solar market. Lelantos also secured exclusive North American rights to a blockchain-based platform for automating carbon and renewable energy credit issuance, positioning itself as a first mover in the next wave of digital carbon trading.

Telomir Pharmaceuticals (NASDAQ: TELO) announced a $3 million equity investment from The Bayshore Trust, the company’s largest shareholder, through the purchase of 1 million restricted shares at $3.00 each—an 18% premium to the stock’s prior closing price. The raise brings total equity investment from affiliated entities to $4 million, complemented by an undrawn $5 million non-dilutive credit line. CEO Erez Aminov emphasized the company’s commitment to shareholder-friendly financing with no warrants or toxic structures. Telomir is advancing two key drug candidates: Telomir-1, a first-in-class age-reversal molecule with broad therapeutic potential, and Telomir-Ag2, a stabilized Silver(II) compound targeting drug-resistant infections. An IND submission for Telomir-1 is planned by year-end, with a focus on rare disease indications to demonstrate early efficacy.

U.S. President Donald Trump has made headlines again, this time not for politics, but for technology and global partnerships. During a high-level visit to the United Arab Emirates (UAE), Trump pledged strong support for the country’s artificial intelligence (AI) projects. He also announced massive new deals between American and Emirati companies, valued at a staggering $200 billion.

The International Energy Agency (IEA) estimates that as of 2024, over 80% of global photovoltaic solar panel production took place in China. Beijing dominates the global solar panel supply chain, and a vast majority of the solar panels installed across the U.S. were manufactured in the East Asian country.

Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) has begun receiving and processing high-grade gold and silver ore from Talisker Resources at its upgraded $33 million Merritt Mill in British Columbia, the province’s only facility permitted to accept third-party precious metal feed. Production is expected to reach full capacity in Q3 2025, and Nicola has initiated a permit amendment to expand mill throughput. The Company is also preparing to receive ore from Blue Lagoon Resources’ Dome Mountain Mine and is advancing a bulk sample at its Dominion Creek project, in which it holds a 75% interest. Concurrently, Nicola is ramping up exploration at the New Craigmont Copper Project and has appointed Vicente García as Senior Geologist. CEO Peter Espig highlighted the company’s transition to a steady-state producer and emphasized the strategic value of its fully permitted infrastructure and long-term partnerships.

Silo Pharma (NASDAQ: SILO) announced a service agreement with Resyca BV to conduct a drug-device study on the microchip-enabled nasal spray system used in its lead PTSD treatment candidate, SPC-15. The study is intended to provide the final device data needed for an Investigational New Drug (IND) application to the FDA later this year. CEO Eric Weisblum noted the device’s ability to bypass the blood-brain barrier, potentially allowing faster and safer therapeutic delivery. Silo is also progressing two other SPC-15 studies, including a GLP-compliant toxicology study and a 7-day large animal safety trial requested by the FDA.

As sports investing gains traction among institutional investors, Brera Holdings (NASDAQ: BREA), a global sports investment group, is positioning itself as a public-market pioneer in the evolving space. With a growing global portfolio of sports clubs and a strategy grounded in sustainability and operational upside, Brera represents an emerging model for investors seeking exposure to professional sports.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced the first patient has been dosed in the Phase 2 OASIS trial evaluating TNX-102 SL for reducing acute stress reaction (ASR) severity and the onset of acute stress disorder (ASD). Sponsored by the University of North Carolina’s Institute for Trauma Recovery and backed by a $3 million U.S. Department of Defense grant, the trial will enroll about 180 motor vehicle trauma survivors at emergency departments nationwide. TNX-102 SL previously showed improvements in sleep and early PTSD symptoms—factors seen as key to mitigating ASR. CEO Dr. Seth Lederman emphasized the urgent need for treatments following traumatic events in both civilian and military populations. Topline data is expected in the second half of 2026.

Gaxos.ai (NASDAQ: GXAI), a company developing artificial intelligence applications across various sectors, announced the official launch of UnGPT.ai, a real-time rewriting tool that converts machine-generated text into natural, human-quality content without compromising meaning. UnGPT leverages a proprietary multi-pass transformation model to deliver undetectable, high-quality output, outperforming leading AI detection tools. The platform includes features such as an adaptive text engine for tone tuning, contextual synonym intelligence, seamless browser integration, and recursive text refinement. CEO Vadim Mats said UnGPT “builds a bridge between raw LLM output and real-world usability.”

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) announced plans for its 2025 regional exploration program at the Storm Copper Project on Somerset Island, Nunavut, operated by American West Metals under a 20/80 joint venture in which Aston Bay holds a free carried interest until a mine decision is made. CEO Thomas Ullrich highlighted key 2025 milestones, including the completion of an NI 43-101 Initial Mineral Resource Estimate, a $1 million royalty milestone payment from Taurus, and a strategic alliance with Ocean Partners to support near-surface copper development. The upcoming summer program will target new discoveries along a 110 km copper belt, expand known deposits, and support resource development through advanced geophysics and drilling. A Preliminary Economic Analysis for the near-surface mineralization is also underway, with impactful developments expected in the second half of the year.

Quantum BioPharma (NASDAQ: QNTM) has partnered with BitGo Trust Company to provide secure, institutional-grade custody for its Bitcoin, Solana, XRP, and DOGE holdings. The biopharmaceutical company, which is building a portfolio of innovative biotech assets, cited security and compliance as key drivers behind the selection of BitGo, known for its multi-signature wallets, cold storage solutions, and insurance-backed infrastructure. CEO Zeeshan Saeed said the partnership strengthens Quantum’s digital asset strategy while reinforcing public company standards.

Brera Holdings (NASDAQ: BREA) announced that S.S. Juve Stabia’s Serie B semifinal playoff match against Cremonese will stream live and air free today in the U.S., Canada and UK via Destination Calcio TV, with full English commentary. The broadcast reflects Brera’s commitment to internationalizing its portfolio club’s exposure as part of its multi-club ownership strategy. Executive Chairman Daniel McClory emphasized that expanding Juve Stabia’s global visibility during its Serie A playoff run showcases the company’s focus on fanbase growth and international media rights. The club, which finished 5th in Serie B, advanced to the semifinals after defeating Palermo 1-0.

OMS Energy Technologies (NASDAQ: OMSE) is a growth-oriented manufacturer of surface wellhead systems and oil country tubular goods for the oil and gas industry. The company recently closed its initial public offering of 3,703,704 ordinary shares, each at a public offering price of US$9.00, for a total base size of US$33.3 million. The ordinary shares began trading on the Nasdaq Capital Market under the symbol OMSE on May 13, and the offering closed on May 14, 2025. In addition, OMS granted the underwriter a 45-day option to purchase up to 555,555 additional ordinary shares at the public offering price, less underwriting discounts and commissions. Roth Capital Partners acted as sole manager for the offering.

For healthcare practices navigating the shift toward value-based care, the complexity of insurance contracts, quality metrics, and data reporting can be a barrier to better outcomes and stronger financial performance. Adageis, a growing healthcare technology company, is offering a unique streamlined and AI-powered software solution designed to make this transition simpler.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that Founder and CEO Dr. Jonathan Javitt will deliver a company update at the Wall Street Conference on May 21, 2025, in Palm Beach, Florida. NRx is one of six companies invited to present at the high-profile event, which is expected to draw more than 1,000 attendees representing over $1 trillion in investment capital.

A proposal backed by Pennsylvania Democrats to allow adults to buy recreational marijuana from state-run stores has been blocked by a Senate panel . The bill was voted down 7-3 by the Senate Law and Justice Committee, with one Democrat siding with Republicans to oppose it.

The private credit market is on the cusp of substantial expansion in 2025, driven by a resurgence in global mergers and acquisitions (“M&A”), the digitization of lending processes and the emergence of innovative financing solutions tailored for small and medium-sized businesses (“SMBs”) ( https://ibn.fm/pDNA4 ). This confluence of factors is reshaping the financial landscape, as companies such as FAVO Capital (OTC: FAVO) are strengthening their foothold in the growing space.

Dr. Richard Lu, CEO of SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., offered insights into the company’s operations, strategy, and unique competitive position during a recent interview on IBN’s GotStocks podcast ( https://ibn.fm/UCIdQ ). The conversation centered on SolarBank’s dual role as both a developer and long-term owner of solar energy assets, an approach that differentiates the firm in a competitive market.

Beeline Holdings (NASDAQ: BLNE) announced the appointment of Frank Knuettel II to its board of directors, effective immediately. Knuettel brings over 20 years of executive leadership experience across early-stage public companies in technology and life sciences, and currently serves as CEO of Channel Therapeutics Corporation. Known for his capital markets expertise and M&A success, including leading Unrivaled Brands from $10 million to $100 million in revenue, Knuettel has raised more than $400 million throughout his career and held key roles at IP Commerce and MJardin Group. His appointment supports Beeline’s growth strategy in the investment lending market.

Siyata Mobile Inc. (NASDAQ: SYTA) is a technology company providing advanced communication solutions for frontline workers, emergency responders, and mobile workforces. Its core offerings include the SD7 push-to-talk handset and Uniden(R)-branded signal boosters, both designed to improve operational connectivity where traditional networks fall short. These products are FCC- and IC-certified and distributed through Tier-1 carriers, integrators, and government purchasing channels.

Tesla’s brand image has taken a significant hit in recent months. For at least a decade, Tesla was the darling of the burgeoning global electric vehicle segment. After launching the Tesla Roadster in 2008 and demonstrating the viability of mass market battery electric vehicles (BEVs), Tesla remained the most dominant player in the EV sector for most of its existence.

In recent weeks, the price of gold has experienced a significant drop, with analysts suggesting that investor sentiment has rapidly shifted, potentially contributing to the precious metal’s selloff. Despite the volatility, some major players are taking renewed interest in this precious metal, among them is billionaire investor Ray Dalio.

For many years, the scientific community has known that the risk of Multiple Sclerosis is markedly higher among people that have been exposed to the Epstein-Barr virus, the virus which causes infectious mononucleosis (commonly called “mono”). However, it isn’t clear why only a tiny fraction of individuals exposed to “mono” go on to develop MS.

UAE and U.S. presidents Sheikh Mohamed bin Zayed Al Nahyan and Donald Trump recently announced the launch of a massive artificial intelligence campus in Abu Dhabi during a high-profile event held at Qasr Al Watan.

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is expanding its international footprint by launching localized websites in Arabic, Italian, and Spanish. The initiative is part of the firm’s strategy to boost commercial activity across high-potential regions with growing demand for workplace safety and compliance solutions ( https://ibn.fm/odRAg ).

Mullen Automotive (NASDAQ: MULN) reported $5 million in revenue for the quarter ended March 31, 2025, a significant increase from $33,000 in the prior-year period, driven by deliveries of Class 1 and Class 3 electric vehicles to customers including logistics firms, local governments and universities. The company also highlighted new agreements, such as a supply deal with Enpower Greentech for advanced solid-state batteries and expanded public sector eligibility via Sourcewell contracts. Bollinger Motors, a majority-owned subsidiary, delivered Class 4 trucks but was placed into court-appointed receivership in May, a move Mullen says will not materially impact its liquidity. For the six-month period, Mullen recorded $7.9 million in revenue and a net loss of $162 million, with $118 million tied to non-cash expenses. Cash on hand declined to $2.3 million, and the company is continuing cost-reduction efforts and financing through convertible securities.

NextPlat (NASDAQ: NXPL, NXPLW) announced that its subsidiary, Global Telesat Communications Ltd (GTC), has been appointed the exclusive distributor for ZOLEO Inc. across the UK and European Economic Area. ZOLEO’s flagship global satellite communicator extends smartphone messaging coverage via the Iridium(R) satellite network and has earned accolades including Outdoor Retailer’s Innovation Award “Product of the Year.” The partnership adds to GTC’s expanding e-commerce and Amazon storefront portfolio of satellite connectivity solutions for remote workers, outdoor enthusiasts, and global travelers.

Cybin (NYSE American: CYBN) (NEO: CYBN) welcomed recent comments from FDA Commissioner Dr. Martin Makary endorsing the accelerated development of psychedelic therapeutics. The company, which is conducting Phase 3 trials of CYB003 for major depressive disorder (MDD) and Phase 2 trials of CYB004 for generalized anxiety disorder (GAD), said the FDA’s openness validates its mission to develop next-generation neuropsychiatric treatments. CYB003, a deuterated psilocin candidate, has received Breakthrough Therapy Designation, and early data show 100% response and 71% remission rates after two 16 mg doses. Cybin expects to launch the EMBRACE Phase 3 trial and complete its Phase 2 GAD study by mid-2025.

Datavault AI (NASDAQ: DVLT), a leader in AI-powered data experience, valuation and monetization, announced it expects to finalize the acquisition of CompuSystems Inc. (CSI) assets today, May 20, 2025. In conjunction with the milestone, the company will host a business update call at 9 a.m. ET. CEO Nathaniel Bradley said the acquisition marks a pivotal step in Datavault’s growth strategy, positioning it to automate and scale revenue-generating deployments across sports, entertainment and event markets. The CSI Division will be led by newly appointed president John Mark LoGiurato, who has been granted 500,000 restricted stock units subject to time- and revenue-based vesting milestones. Datavault expects CSI to deliver the majority of its projected $12 million to $15 million in second-half 2025 revenue, and contribute $15 million to $20 million toward 2026 targets.

Quantum BioPharma (NASDAQ: QNTM) has signed an agreement with a global pharmaceutical contract research organization to prepare an Investigational New Drug (IND) application for its lead compound, Lucid-21-302 (Lucid-MS), targeting multiple sclerosis. The IND submission to the FDA is planned for the fourth quarter of 2025 and, if accepted, would enable the company to initiate a Phase 2 clinical trial. Lucid-21-302 is a patented, non-immunomodulatory neuroprotective therapy shown in preclinical studies to prevent demyelination, a key driver of MS and other neurodegenerative disorders.

NRx Pharmaceuticals (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company developing therapies for central nervous system disorders, particularly suicidal depression and PTSD. The company is leveraging its patented NMDA receptor modulation platform with two drugs, NRX-100 (preservative-free ketamine) and NRX-101 (D-cycloserine/lurasidone), that have received FDA Fast Track and Breakthrough Therapy designations, respectively. Both address acute unmet medical needs, in that there is no FDA-approved medication for suicidal depression and PTSD. The only approved treatment today is electroshock therapy.

The global adoption of battery electric vehicles (BEVs) is having a notable effect on oil demand across several key markets. Oil has been the primary source of energy for the transport industry for over a century, and a large portion of the world’s infrastructure grew around the extraction, refining, and distribution of oil and petroleum products. Although this reliance on oil has significantly contributed to premature atmospheric heating and accelerated climate change, fossil fuels were integral to the transport sector and several other energy-intensive industries.

The French government is stepping up efforts to protect the cryptocurrency sector by introducing enhanced security measures for industry professionals and their families. Authorities are now offering crypto entrepreneurs priority access to emergency police services, in-home visits by law enforcement, and customized security briefings.

Standard Chartered, also known as Stanchart, is making big moves in the world of investment banking. The bank has set up a new team in the United States to focus on private equity firms, hedge funds, and other big financial investors. This is part of its plan to grow its investment banking business and earn more from financial clients.

Thumzup (NASDAQ: TZUP) announced that CEO Robert Steele will present at the 82nd Emerging Growth Conference on May 21, 2025, at 11:25 a.m. ET. The company will showcase its disruptive platform that pays everyday consumers to post about participating brands on social media, enabling scalable, user-generated advertising. Hosted virtually, the conference highlights innovative small- and micro-cap companies positioned for long-term growth.

In a closely split 5-4 ruling, the U.S. Supreme Court recently sided with a commercial truck driver who sued three CBD firms under the federal RICO statute. The driver, Douglas Horn, claimed he was fired after a drug test came back positive for THC, despite using a CBD product that was labeled as THC-free.

Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of Republican lawmakers advocating for the therapeutic use of psychedelics to treat PTSD, depression, and suicidality among veterans—a movement recently spotlighted by The Wall Street Journal . After undergoing ibogaine and DMT therapy in Mexico in 2018, Luttrell described the experience as transformative, helping him confront trauma and save his marriage. Now in Congress, he’s pushing for science-based, medically supervised access to Schedule I drugs like ibogaine, psilocybin, and MDMA. Joined by fellow veterans in office, including Rep. Dan Crenshaw (R-Texas) and Rep. Jack Bergman (R-Mich.), Luttrell is helping lead legislative efforts to fund clinical trials through the VA and Pentagon, despite resistance from some conservatives and recent regulatory setbacks like the FDA’s rejection of an MDMA therapy from Lykos Therapeutics.

In today’s world, social media is a powerful tool for brands. It helps them talk to their customers, share their stories, and grow their business. But with so many users and so much content online, it’s not always easy for brands to stand out or know what their audience wants. This is where artificial intelligence (AI) comes in. AI is changing the way brands connect with people on social media by making things faster, smarter, and more personal.

The GOP administration recently released another round of AI chip export restrictions against China to prevent it from acquiring advanced semiconductors from American chipmakers. This announcement came as Nvidia CEO Jensen Huang was unveiling the Blackwell architecture and a major AI partnership in Saudi Arabia. The U.S. Commerce Department has issued a warning against using American-made AI chips in Chinese models and condemned diversionary supply chain tactics that attempt to circumvent these restrictions.

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company dedicated to developing and commercializing treatments for rare diseases, recently announced its financial results for the first quarter of 2025, alongside a summary of the company’s latest accomplishments ( https://ibn.fm/OMQmM ). These milestones are representative of Soligenix’s continued commitment to advance its pipeline of therapeutic candidates, focusing on areas with significant unmet medical needs.

Aditxt (NASDAQ: ADTX), a social innovation platform advancing health innovations, announced its decision to terminate the Arrangement Agreement with Appili Therapeutics Inc., effective May 31, 2025. The agreement, first announced in April 2024, had been amended multiple times to address evolving conditions. Aditxt cited a lack of strategic alignment as the reason for discontinuing the deal, despite ongoing respect for Appili’s work. Management plans to formally notify Appili of the termination.

Effective leadership is a cornerstone of organizational success, particularly in the dynamic and high-stakes realm of biotechnology. Recognizing the pivotal role of seasoned leadership, Calidi Biotherapeutics (NYSE American: CLDI) has announced the appointment of Eric Poma, PhD, as its new Chief Executive Officer and member of the board of directors ( https://ibn.fm/qMEu4 ). This strategic transition underscores Calidi’s commitment to advancing its innovative cancer therapies under experienced guidance. Dr. Poma succeeds Allan Camaisa, who will continue to serve as a board member.

Silo Pharma (NASDAQ: SILO) a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, closed a public offering totaling approximately $2 million in gross proceeds. The offering included 3,333,338 shares of common stock or pre-funded warrants, along with Series A-1 and Series A-2 warrants, each allowing the purchase of up to 3,333,338 shares at $0.60 per share. The Series A-1 Warrants expire in five years, while the Series A-2 Warrants expire in eighteen months. H.C. Wainwright & Co. acted as the exclusive placement agent. Proceeds will be used for general working capital.

Scrap copper exports effectively came to a sudden halt after Trump started a trade war with China and other trading partners around the world. China imports more than 50% of the scrap copper collected in the U.S., and the prohibitive tariffs between these major trading partners made it nearly impossible for this metal to change hands.

SolarBank (NASDAQ: SUUN) (CSE: SUNN) posted fiscal Q3 results for the period ended March 31, 2025, showing year-to-date revenue of C$29.1 million versus C$50.4 million a year earlier, reflecting a shift toward long-term asset ownership over short-term EPC sales. The company reported a net loss of C$9 million compared to net income of C$5.5 million last year, driven by higher costs and reduced EPC activity. SolarBank highlighted a 395% increase in assets to C$194 million following the Solar Flow-Through Funds acquisition and secured a mandate letter with CIM Group for up to US$100 million in project financing for a 97 MW solar portfolio in the U.S., reinforcing its strategy to grow its independent power producer platform.

Efforts to legalize recreational cannabis through a constitutional amendment in Florida are facing a new hurdle: a recently passed state law that adds major roadblocks to the citizen initiative process. The group leading the marijuana amendment push, Smart & Safe Florida, has joined a federal lawsuit challenging the new law, arguing that it undermines Floridians’ fundamental right to propose and vote on constitutional changes.

Capstone Holding (NASDAQ: CAPS) reaffirmed its 2025 targets of a $100 million revenue run-rate and $10 million in adjusted EBITDA, supported by a strong M&A pipeline and disciplined cost control. The company is evaluating acquisition opportunities at 4–6x EBITDA multiples, with up to 45% non-cash consideration, and has secured an equity line of credit to support deals without upfront dilution. Subsidiary Instone remained on track despite seasonal headwinds, with cost run-rate guidance intact and growth expected to pick up in Q3.

As the global economy continues to evolve and diversify, investors are seeking opportunities in sectors with long-term growth potential and strong fundamentals. Precious metals, long viewed as stores of value and industrial cornerstones, are receiving renewed attention, particularly palladium. With its essential role in automotive, industrial and emerging technology applications, palladium is poised to remain a critical element in 2025 and beyond. Platinum Group Metals (NYSE American: PLG) (TSX: PTM), a development stage mining company, is strategically positioned to benefit from this momentum.

As artificial intelligence (“AI”) continues to revolutionize industries, the infrastructure supporting its growth — particularly data centers — has become increasingly reliant on copper due to its superior electrical conductivity. This surge in demand for copper presents significant opportunities for mining companies such as Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), which is strategically positioned to supply this critical resource.

Brera Holdings (NASDAQ: BREA), a global sports investment group, announced the signing of a letter of intent to introduce the digital engagement platform PLAY LEAP to its portfolio of clubs, beginning with Italian Serie B side Juve Stabia. The initiative is part of a wider strategy to generate new digital revenue streams and broaden fan interaction and engagement.

Pre-production gold and silver resource developer ESGold (CSE: ESAU) (OTCQB: ESAUF) is announcing the appointment of seasoned mining executive and former global investment banker Peter Espig to its Board of Directors, establishing a vital leadership resource for the company as it prepares to transform itself from an exploration-stage junior into one of Canada’s important precious metals producers.

Bionoid Pharma (OTC PINK: BINP) has rebranded as AI Maverick Intel, Inc., signaling a strategic pivot toward artificial intelligence-powered customer acquisition and engagement solutions. The transformation follows the acquisition of AI Maverick Intel, a platform specializing in AI-based audience automation and intelligent two-way communication. The company aims to deploy its proprietary technology across healthcare, biotech, and other sectors to enhance targeting, engagement, and operational efficiency.

CNS Pharmaceuticals (NASDAQ: CNSP) reported a Q1 2025 net loss of $4.3 million, up from $3.5 million in the prior year period, as R&D spending increased to support data analysis for its Berubicin trial. The company remains focused on advancing TPI 287, a novel taxane with the potential to treat glioblastoma by crossing the blood-brain barrier. CNS has secured Orphan Drug Designation for TPI 287 and plans to initiate a Phase 2 study in recurrent GBM by late 2025. With $13.1 million in cash at quarter-end and an additional $5 million raised in May, the company expects to fund operations into the second half of 2026.

This week saw the prices of gold and silver futures drop as more reports showed that the U.S. and China’s trade war was easing. July silver prices dropped to $32.44 while June gold declined to $3222.50.

The recently unveiled Slate Truck could usher in a new age of electric mobility characterized by affordable and accessible electric pickup trucks. Approximately 47% of Americans own a pickup truck, with full-size models from the Ford F-Series, Chevrolet, and Ram being especially popular in the country. As automakers began pivoting to electric cars, some opted to develop electric trucks to tap into North America’s well-known demand for pickups.

Early diagnosis of lung cancer is pivotal to effective treatment because this disease is very challenging to treat. Advances in AI are transforming the screening for this disease, improving both efficiency and accuracy. Existing screening methods such as low-dose CT have several challenges. These include high rates of false-positives and a high variability when reporting other incidental but critical information, such as findings on cardiovascular diseases.

Artificial intelligence (AI) is often discussed through the lens of massive corporations, but that perspective overlooks the powerful influence small and medium-sized businesses (SMBs) have on the global economy.

FingerMotion (NASDAQ: FNGR), has entered the Indonesian market via its subsidiary, Finger Motion Financial Company Limited, by signing an agreement with PT Mach Wireless Teknologi to deploy its AI-driven insurance risk rating platform. Tailored for local underwriting in motor, health, and life insurance, the platform will integrate with Indonesia’s telco-insurance ecosystem. The company is in final talks with a major Indonesian telecom provider to support the rollout. This marks a key milestone in FingerMotion’s Southeast Asia expansion strategy, blending AI, big data, and regional partnerships to transform digital insurance delivery.

NanoViricides, Inc. (NYSE American: NNVC) filed its Q1 2025 report and announced progress on NV-387, its broad-spectrum antiviral drug candidate. The company has received clearance from the DRC’s National Ethics Committee to submit a Phase II trial application for MPox and is also initiating programs targeting measles and avian flu. NV-387 previously completed Phase I with no adverse events and has shown superior activity in animal models compared to approved antivirals for COVID, influenza, RSV, and smallpox. Financially, NNVC reported $2.73 million in cash, $6.98 million in property and equipment, and $1.2 million in current liabilities, but indicated that additional funding is needed to support operations beyond early 2026.

Silo Pharma (NASDAQ: SILO) has priced a public offering of approximately 3.33 million shares of common stock (or pre-funded warrants) along with Series A-1 and Series A-2 warrants, all priced at $0.60 per unit. The Series A-1 and A-2 warrants are immediately exercisable at $0.60 per share, with expirations set at five years and eighteen months, respectively. Gross proceeds are expected to total roughly $2 million before fees and expenses. H.C. Wainwright & Co. is acting as the exclusive placement agent, and proceeds will support general working capital.

French authorities are currently investigating a disturbing trend involving the abduction of individuals tied to the crypto world. The latest case involves a 60-year-old man whose finger was severed by kidnappers demanding that his son, a crypto-millionaire, pay ransom for his release. The victim, who runs a crypto marketing firm alongside his son, was held captive for over two days before being rescued by police.

German authorities have confiscated around $38 million worth of cryptocurrency from an exchange known as eXch, a platform suspected of helping cybercriminals launder stolen funds. This includes money linked to the $1.4 billion Bybit hack that happened earlier this year.

The entire Iberian Peninsula recently experienced a massive blackout that left most of mainland Spain, Portugal, and parts of southern France without electrical power for around 10 hours. Some opposition parties in Spain, as well as a few external observers, have pointed to net-zero emission goals and renewable energy targets as potential contributors to the outage .

SolarBank (NASDAQ: SUUN) (CSE: SUNN) President and CEO Dr. Richard Lu appeared on the GotStocks Podcast to discuss the company’s vertically integrated model and its $184 million portfolio of revenue-generating clean energy assets. Lu detailed how SolarBank develops, builds, owns, and operates distributed and community solar projects across Canada and the U.S., including partnerships with Honeywell and Qcells. He also highlighted a recent $100 million financing agreement with CIM Group to fund 97 MW of U.S. projects, positioning the company for continued long-term growth.

NRx Pharmaceuticals (NASDAQ: NRXP) reported a Q1 2025 net loss of $5.5 million, down from $6.5 million in the same period last year, with operating losses narrowing to $3.8 million. The company advanced regulatory and commercial milestones for its two lead programs: NRX-100, a preservative-free IV ketamine formulation for suicidal depression now supported by an NDA fee waiver and new patent filing; and NRX-101, an oral treatment for bipolar depression with a PDUFA date anticipated before year-end. Subsidiary HOPE Therapeutics also gained momentum with $10.3 million in new acquisition funding to support a national psychiatry clinic rollup. NRx ended the quarter with $5.5 million in cash and expects its current capital and financing plans to support operations through year-end.

The marijuana sector is facing a growing financial crisis that’s been developing quietly while many businesses ignore the signs. The core issue? An explosion in unpaid invoices that’s threatening to destabilize the entire supply chain. Despite some whispers in online forums and informal industry circles, there has been little serious discussion about the scale of the problem or the risks it poses.

Adageis, a forward-thinking healthcare technology company, is empowering clinics and medical groups to succeed in the shift from fee-for-service to value-based care through its AI-powered platform. The company’s ProActive Care solution deciphers complex insurance contracts, integrates with leading EHR systems, and offers real-time analytics to help providers track revenue trends as well as their performance and profitability. Proprietary components of the platform, including the Value-Based Care Engine and Patented Risk Engine, identify care gaps and high-risk patients, enabling earlier interventions that enhance both clinical and financial performance. By developing targeted solutions, with a focus on smaller and independent practices, Adageis aims to make value-based care more accessible and profitable while driving data-driven operational decisions.

Nutriband (NASDAQ: NTRB), a company focused on the development of a portfolio of transdermal pharmaceutical products, is expanding its market presence and manufacturing capabilities through two new strategic partnerships. The company is collaborating with Charlotte FC to build brand visibility, particularly for its AI Tape and AVERSA(TM)—Nutriband’s proprietary technology that it believes has the potential to be the world’s first and only abuse deterrent patch platform for managing chronic pain. The company also deepened its collaboration with Kindeva Drug Delivery through an amended agreement focused on the development of Aversa(TM) Fentanyl, which combines Nutriband’s abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch. Through existing and new alliances with established brands in the health and wellness industry, Nutriband aims to diversify its revenue streams and reinforce its position as a leader in transdermal drug delivery solutions.